+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Immunoprecipitation Market by Product, Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5533317
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immunoprecipitation Market grew from USD 1.36 billion in 2023 to USD 1.64 billion in 2024. It is expected to continue growing at a CAGR of 20.78%, reaching USD 5.13 billion by 2030.

Immunoprecipitation (IP) is a critical technique in laboratory research used to isolate a specific antigen from a complex protein mixture, leveraging its interaction with a target-specific antibody. Its necessity in the scientific community stems from its extensive application in protein biology, including studies on protein interactions, expression, post-translational modifications, and cellular localization. The end-use scope of immunoprecipitation spans academic and research institutes, biotechnology and pharmaceutical companies, and clinical laboratories, driving innovation in drug discovery and the development of targeted therapies. Key growth factors for the immunoprecipitation market include advances in molecular biology, increased funding for research activities, and the expanding biopharmaceutical sector. Additionally, continuous collaborations between academic institutions and biotechnology firms enhance technological capabilities, potentially creating added value in the market. However, challenges such as the complexity of workflows, variability of results due to antibody specificity, and the requirement for high technical expertise may hinder broader adoption in less-resourced settings. Moreover, high costs associated with reagents and instruments could constrain market growth, particularly in emerging countries. Opportunities arise with the integration of automation in immunoprecipitation processes, yielding improved reproducibility and efficiency, capitalizing on nanotechnology, and expanding into personalized medicine frameworks. Consequently, the best areas for innovation and research include developing more robust and high-throughput methodologies, leveraging bioinformatics to interpret complex datasets, and enhancing the sensitivity and specificity of antibodies used, which could profoundly impact the future market landscape. Despite its moderately competitive nature, the immunoprecipitation market is ripe for innovation, particularly in areas that can simplify methodologies and improve accuracy. Companies focusing on these areas can better address current limitations and strategically position themselves to capture emerging opportunities for significant business growth.

Understanding Market Dynamics in the Immunoprecipitation Market

The Immunoprecipitation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing applications of immunoprecipitation testing in central nervous disorders
    • Rise in the number of life science experiments and research activities
    • Development of improved protocols for chromatin immunoprecipitation
  • Market Restraints
    • Presence of alternative technologies for protein purification
  • Market Opportunities
    • Advancements in immunoprecipitation techniques
    • Rising investments by governments and various industries
  • Market Challenges
    • Issues related to quality over research antibodies

Exploring Porter’s Five Forces for the Immunoprecipitation Market

Porter’s Five Forces framework further strengthens the insights of the Immunoprecipitation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Immunoprecipitation Market

External macro-environmental factors deeply influence the performance of the Immunoprecipitation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Immunoprecipitation Market

The Immunoprecipitation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Immunoprecipitation Market

The Immunoprecipitation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Immunoprecipitation Market

The Immunoprecipitation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprecipitation Market, highlighting leading vendors and their innovative profiles. These include Abbkine Scientific Co., Ltd, Abcam PLC, Axil Scientific Pte Ltd., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer Inc., Cell Signaling Technology, Inc., Creative Biomart Inc., Cytoskeleton, Inc., EpiGentek Group Inc., Geno Technology, Inc., LifeSpan BioSciences, Inc., MyJoVE Corporation, Proteintech Group, Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Immunoprecipitation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Accessories
      • Primary Antibodies
      • Secondary Antibodies
    • Beads
      • Agarose Beads
      • Buffers
      • Magnetic Beads
    • Kits
    • Reagents
  • Type
    • Chromatin Immunoprecipitation
    • Co-Immunoprecipitation
    • Individual Immunoprecipitation
    • RNA Immunoprecipitation
  • End-User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing applications of immunoprecipitation testing in central nervous disorders
5.1.1.2. Rise in the number of life science experiments and research activities
5.1.1.3. Development of improved protocols for chromatin immunoprecipitation
5.1.2. Restraints
5.1.2.1. Presence of alternative technologies for protein purification
5.1.3. Opportunities
5.1.3.1. Advancements in immunoprecipitation techniques
5.1.3.2. Rising investments by governments and various industries
5.1.4. Challenges
5.1.4.1. Issues related to quality over research antibodies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Immunoprecipitation Market, by Product
6.1. Introduction
6.2. Accessories
6.2.1. Primary Antibodies
6.2.2. Secondary Antibodies
6.3. Beads
6.3.1. Agarose Beads
6.3.2. Buffers
6.3.3. Magnetic Beads
6.4. Kits
6.5. Reagents
7. Immunoprecipitation Market, by Type
7.1. Introduction
7.2. Chromatin Immunoprecipitation
7.3. Co-Immunoprecipitation
7.4. Individual Immunoprecipitation
7.5. RNA Immunoprecipitation
8. Immunoprecipitation Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Immunoprecipitation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Immunoprecipitation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Immunoprecipitation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOPRECIPITATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IMMUNOPRECIPITATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOPRECIPITATION MARKET DYNAMICS
TABLE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CHROMATIN IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CO-IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY INDIVIDUAL IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RNA IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 46. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 47. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 51. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 73. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 74. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 78. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 79. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 88. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 89. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 118. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 119. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 134. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 135. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 139. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 140. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 144. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 145. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 149. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 164. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 165. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 179. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 184. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 185. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 189. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 190. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 209. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 224. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Immunoprecipitation Market, which are profiled in this report, include:
  • Abbkine Scientific Co., Ltd
  • Abcam PLC
  • Axil Scientific Pte Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioLegend, Inc. by PerkinElmer Inc.
  • Cell Signaling Technology, Inc.
  • Creative Biomart Inc.
  • Cytoskeleton, Inc.
  • EpiGentek Group Inc.
  • Geno Technology, Inc.
  • LifeSpan BioSciences, Inc.
  • MyJoVE Corporation
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information